| Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ... The Journal of clinical investigation 126 (8), 3036-3052, 2016 | 632 | 2016 |
| CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression K Fousek, J Watanabe, SK Joseph, A George, X An, TT Byrd, JS Morris, ... Leukemia 35 (1), 75-89, 2021 | 137 | 2021 |
| Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma M Hegde, SK Joseph, F Pashankar, C DeRenzo, K Sanber, S Navai, ... Nature communications 11 (1), 3549, 2020 | 117 | 2020 |
| Abstract LB-147: Administration of HER2-CAR T cells after lymphodepletion safely improves T cell expansion and induces clinical responses in patients with advanced sarcomas SA Navai, C Derenzo, S Joseph, K Sanber, T Byrd, H Zhang, M Mata, ... Cancer Research 79 (13_Supplement), LB-147-LB-147, 2019 | 48 | 2019 |
| Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ... The Journal of clinical investigation 129 (8), 3464-3464, 2019 | 23 | 2019 |
| Targeting primary pre-B cell acute lymphoblastic leukemia and CD19-negative relapses using trivalent CAR T cells K Fousek, J Watanabe, A George, X An, H Samaha, SA Navai, TT Byrd, ... Blood 130, 4614, 2017 | 19 | 2017 |
| Malignant melanoma incidence among children and adolescents in Texas and SEER 13, 1995–2013 HE Danysh, SA Navai, ME Scheurer, R Hunt, R Venkatramani Pediatric blood & cancer 66 (6), e27648, 2019 | 16 | 2019 |
| Incidence and predictors of treatment‐related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia SK Hashmi, SA Navai, TM Chambers, ME Scheurer, MJ Hicks, RE Rau, ... Pediatric blood & cancer 67 (2), e28063, 2020 | 15 | 2020 |
| Targeting the tumour profile using broad spectrum chimaeric antigen receptor T-cells SA Navai, N Ahmed Biochemical Society Transactions 44 (2), 391-396, 2016 | 15 | 2016 |
| Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ... The Journal of Clinical Investigation 131 (13), 2021 | 9 | 2021 |
| Severe COVID-19 infection in a child receiving immunotherapy for cancer VR Smith, SB Whittle, RD Coleman, FM Munoz, MM De Guzman, ... Pediatric blood & cancer 68 (3), e28710, 2021 | 9 | 2021 |
| Targeting CD19-negative relapsed B-acute lymphoblastic leukemia using trivalent CAR T cells. K Fousek, J Watanabe, A George, X An, HS Samaha, SA Navai, TT Byrd, ... Journal of Clinical Oncology 36 (5_suppl), 121-121, 2018 | 9 | 2018 |
| Pediatric liposarcoma: A case series and literature review YI Baday, SA Navai, MJ Hicks, R Venkatramani, SB Whittle Pediatric Blood & Cancer 68 (12), e29327, 2021 | 2 | 2021 |
| Abstract A50: Trivalent CAR T cells mitigate CD19-negative relapse and improve tumor control in primary pre-B cell acute lymphoblastic leukemia (B-ALL) K Fousek, J Watanabe, X An, A George, H Samaha, S Navai, TT Byrd, ... Cancer Immunology Research 6 (9_Supplement), A50-A50, 2018 | 1 | 2018 |
| A Bispecific Chimeric Antigen Receptor Molecule Enhances the Anti-Glioblastoma Efficacy of T Cells Through Dual Immunological Synapse Formation M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, A Wakefield, ... Cytotherapy 18 (6), S8-S9, 2016 | 1 | 2016 |
| Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial M Hegde, S Navai, C DeRenzo, SK Joseph, K Sanber, M Wu, AZ Gad, ... Nature Cancer, 1-15, 2024 | | 2024 |
| 803: CARDIOTOXICITY OF IMMUNE EFFECTOR CELLULAR THERAPIES IN PEDIATRIC HEMATOLOGIC AND SOLID TUMORS A Ross, K Puri, N Rainusso, S Navai, N Ahmed, M Hegde, B Omer, ... Critical Care Medicine 52 (1), S374, 2024 | | 2024 |
| Autologous HER2-specific CAR T-cells after lymphodepletion for advanced sarcoma M Hegde, S Navai, C DeRenzo, S Joseph, K Sanber, MF Wu, K Janeway, ... | | 2023 |
| Advancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board P Mahajan, S Navai, V Smith, S Potter, R Venkatramani Pediatric Hematology and Oncology 39 (7), 678-680, 2022 | | 2022 |
| 412 Synthetic PD-1 co-stimulatory molecule preserves a cytolytic CAR T cell immune synapse while reducing tonic signaling R Brock, J Morris, A Gad, D Landi, S Navai, Z Nawas, S Joseph, N Ahmed, ... J Immunother 10 (2), A1-A1595, 2022 | | 2022 |
